Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Verax Biomedical Inc.

veraxbiomedical.com

Latest From Verax Biomedical Inc.

Pathogen-Reduction Tech Gets Some Focus At FDA Panel Meeting, But Not Enough, Cerus Says

While a panel of US FDA experts agreed that pathogen reduction technology is a promising strategy for reducing blood platelet contaminations, they raised concerns about the cost of implementing the technology. The maker of the technology, Cerus, says the panel was under-briefed and distracted.

Advisory Committees FDA

Medtech Execs On The Move, March 2016

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

See All

Company Information

  • Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Medical Devices
    • Infection Control-Sterilization
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Verax Biomedical Inc.
  • Senior Management
  • Joe L Straight, CEO
    Joe R Sanders, VP, Mktg. & Bus. Dev.
  • Contact Info
  • Verax Biomedical Inc.
    Phone: (508) 755-7029
    377 Plantation St.
    Worcester, MA 01605
    USA
UsernamePublicRestriction

Register